Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment.

Sun, Yifei; Moghekar, Abhay; Soldan, Anja; Pettigrew, Corinne; Greenberg, Barry; Albert, Marilyn; Wang, Mei-Cheng

Sun, Yifei; Moghekar, Abhay; Soldan, Anja; Pettigrew, Corinne; Greenberg, Barry; Albert, Marilyn; Wang, Mei-Cheng.

Affiliation

Sun Y; Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA.
Moghekar A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Soldan A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pettigrew C; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Greenberg B; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Albert M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Wang MC; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

J Alzheimers Dis ; 96(1): 287-300, 2023.

Article de En | MEDLINE | ID: mdl-37742656

Sujet(s)
Mots clés

APOE genotype; Alzheimer's disease; amyloid; biomarkers; cerebrospinal fluid; preclinical AD; tau

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie d'Alzheimer / Dysfonctionnement cognitif Type d'étude: Prognostic_studies Limites: Female / Humans Langue: En Journal: J Alzheimers Dis Sujet du journal: GERIATRIA / NEUROLOGIA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google